Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-14 Purchase | 2023-06-15 8:13 pm | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 30,000 | $0.2149 | $6,447 | 563,223 (Indirect Direct) | View |
| 2022-12-22 Purchase | 2022-12-27 6:47 pm | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 25,000 | $0.285 | $7,125 | 533,223 (Indirect Direct) | View |
| 2022-08-15 Purchase | 2022-08-17 8:20 pm | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 10,000 | $0.97 | $9,700 | 553,223 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Chairman | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 9:30 pm | N/A 2033-06-23 | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 110,000 | $0 | 673,223 (Direct) | View |
Ownership | 2023-02-14 4:16 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 0 | $0 | 6,849,242 (Indirect) | View |
| 2022-12-01 Ownership | 2023-02-14 4:16 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 25,000 | $0 | 6,849,242 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 8:20 pm | N/A 2032-08-15 | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 55,000 | $0 | 553,223 (Direct) | View |
| 2022-06-24 Exercise | 2022-07-19 4:05 pm | N/A N/A | Oncocyte Corp | OCX | KINGSLEY ALFRED D Director | 10,000 | $0 | 394,111 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2022-02-11 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 0 | $0 | 6,874,242 (Indirect) | View |
| 2021-12-01 Ownership | 2022-02-11 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 14,700 | $0 | 6,874,242 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:21 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 8:32 pm | N/A 2031-06-23 | OncoCyte Corp | OCX | KINGSLEY ALFRED D Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-06-22 Exercise | 2021-06-23 1:15 pm | N/A 2021-06-30 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 61,800 | $0 | 6,888,942 (Direct) | View |
| 2021-06-22 Exercise | 2021-06-23 1:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 61,800 | $2.2 | 6,888,942 (Direct) | View |